PGR and breast cancer: Furthermore, nuclear TTP modulated the transactivation activity of progesterone receptor (PR), glucocorticoid receptor (GR) and androgen receptor (AR) and acted as a co‐repressor of PR, GR and AR in breast cancer (Barrios‐Garcia et al., 2016).